Tag Archives: Gene Editing

Rockefeller University posts Eugenicist / Globalist David’s Death

US billionaire philanthropist David Rockefeller dies at 101

“While it is impossible to imagine the University without David, he will live on in every scientific advance and breakthrough made in University laboratories”



“Under his leadership, Chase was the first US bank to open offices in the Soviet Union and China.
In 1974, it was the first to open an office in Egypt after the Suez crisis of 1956.
He was also behind the project that led to the World Trade Center in New York City.
Mr Rockefeller retired in 1981 aged 65
Former President George HW Bush and his wife, Barbara, released a statement saying they were “deeply saddened” by the passing of their “wonderful friend”

He had six children – David Jr, Richard, Abby, Neva, Margaret and Eileen – with his wife Margaret (nee McGrath). She died in 1996.”

See Also: 5 Reasons Billionaire David Rockefeller Won’t Be Missed

Note: This great philanthropist, did not fund the hemp plant as an alternative to OIL for plastics, drugs, energy. He did not explore natural means to boost immunity, he did not explore how to inform the public about the nature of the deceit of debt based money. As an economist did he inform US presidents of the deceit of  central banks? He did not fund the potential exponential gains in solar technology that could have followed the same trajectory as the microprocessor.

In short you could assert that technologies/information that empowered humanity are rejected, ignored by this philanthropist.

What are these globalist getting excited about now? Gene editing and manipulation. Permanent change in the gene pool.

EDITAS: The Hottest IPO of 2016 Is Crashing

The Hottest IPO of 2016 Is Crashing

Shares of startup gene editing biotech Editas, which had the first U.S. IPO of 2016, plunged nearly 26% in Tuesday trading after enjoying more than a month as the runaway most successful firm to go public this year

As The Street notes, one major reason for Editas’ success over its 2016 IPO peers is a heavy-hitting roster of investors which includes Bill Gates, Google Ventures, and Fidelity Investments, and others

The more likely possibility is the important impending court proceedings over a CRISPR patent dispute between the University of California and the Broad Institute/Massachusetts Institute of Technology which could shake things up in the market.